{"symbol": "SGEN", "companyName": "Seattle Genetics Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.seattlegenetics.com", "description": "Seattle Genetics Inc is a biotechnology company. The company is focused on development and commercialization of targeted therapies for the treatment of cancer. Its products are ADCETRIS (brentuximab vedotin) US and ADCETRIS (brentuximab vedotin) Canada.", "CEO": "Clay B. Siegall", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}